Annual Total Debt
$30.95 M
+$6.05 M+24.32%
December 31, 2023
Summary
- As of February 12, 2025, FENC annual total debt is $30.95 million, with the most recent change of +$6.05 million (+24.32%) on December 31, 2023.
- During the last 3 years, FENC annual total debt has risen by +$30.95 million (+100.00%).
- FENC annual total debt is now at all-time high.
Performance
FENC Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$32.10 M
+$316.00 K+0.99%
September 30, 2024
Summary
- As of February 12, 2025, FENC quarterly total debt is $32.10 million, with the most recent change of +$316.00 thousand (+0.99%) on September 30, 2024.
- Over the past year, FENC quarterly total debt has increased by +$316.00 thousand (+0.99%).
- FENC quarterly total debt is now at all-time high.
Performance
FENC Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
FENC Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.3% | +1.0% |
3 y3 years | +100.0% | +27.7% |
5 y5 years | +100.0% | +27.7% |
FENC Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +520.6% | at high | +543.6% |
5 y | 5-year | at high | -100.0% | at high | -100.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Fennec Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $32.10 M(+1.0%) |
Jun 2024 | - | $31.79 M(+1.3%) |
Mar 2024 | - | $31.37 M(+1.3%) |
Dec 2023 | $30.95 M(+24.3%) | $30.95 M(+20.6%) |
Sep 2023 | - | $25.67 M(+1.1%) |
Jun 2023 | - | $25.39 M(+1.0%) |
Mar 2023 | - | $25.14 M(+1.0%) |
Dec 2022 | $24.90 M(+399.2%) | $24.90 M(+0.9%) |
Sep 2022 | - | $24.69 M(+394.7%) |
Jun 2022 | - | $4.99 M(+0.0%) |
Mar 2022 | - | $4.99 M(+0.0%) |
Dec 2021 | $4.99 M(>+9900.0%) | $4.99 M(+0.0%) |
Sep 2021 | - | $4.99 M(+0.0%) |
Jun 2021 | - | $4.99 M(>+9900.0%) |
Mar 2021 | - | $0.00(0.0%) |
Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2020 | - | $0.00(0.0%) |
Jun 2020 | - | $0.00(0.0%) |
Mar 2020 | - | $0.00(0.0%) |
Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2019 | - | $0.00(0.0%) |
Jun 2019 | - | $0.00(0.0%) |
Mar 2019 | - | $0.00(0.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) |
Mar 2008 | - | $0.00(0.0%) |
Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2007 | - | $0.00(0.0%) |
Jun 2007 | - | $0.00(0.0%) |
Mar 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) |
Jun 2004 | $0.00(-100.0%) | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) |
Dec 2003 | - | $0.00(-100.0%) |
Sep 2003 | - | $170.30 K(-85.6%) |
Jun 2003 | $1.18 M(>+9900.0%) | $1.18 M(+738.3%) |
Mar 2003 | - | $140.90 K(>+9900.0%) |
Dec 2002 | - | $0.00(-100.0%) |
Sep 2002 | - | $56.60 K(>+9900.0%) |
Jun 2002 | $0.00(-100.0%) | $0.00(0.0%) |
Mar 2002 | - | $0.00(-100.0%) |
Dec 2001 | - | $56.40 K(+116.1%) |
Sep 2001 | - | $26.10 K(-21.9%) |
Jun 2001 | $33.40 K(-43.4%) | $33.40 K(>+9900.0%) |
Mar 2001 | - | $0.00(-100.0%) |
Dec 2000 | - | $46.00 K(>+9900.0%) |
Sep 2000 | - | $0.00 |
Jun 2000 | $59.00 K | - |
FAQ
- What is Fennec Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual total debt year-on-year change?
- What is Fennec Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly total debt year-on-year change?
What is Fennec Pharmaceuticals annual total debt?
The current annual total debt of FENC is $30.95 M
What is the all time high annual total debt for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total debt is $30.95 M
What is Fennec Pharmaceuticals annual total debt year-on-year change?
Over the past year, FENC annual total debt has changed by +$6.05 M (+24.32%)
What is Fennec Pharmaceuticals quarterly total debt?
The current quarterly total debt of FENC is $32.10 M
What is the all time high quarterly total debt for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total debt is $32.10 M
What is Fennec Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, FENC quarterly total debt has changed by +$316.00 K (+0.99%)